These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 21305642)
21. Amplified MYCN in human neuroblastoma: paradigm for the translation of molecular genetics to clinical oncology. Schwab M Ann N Y Acad Sci; 2002 Jun; 963():63-73. PubMed ID: 12095930 [TBL] [Abstract][Full Text] [Related]
22. MYCN and ALKF1174L are sufficient to drive neuroblastoma development from neural crest progenitor cells. Schulte JH; Lindner S; Bohrer A; Maurer J; De Preter K; Lefever S; Heukamp L; Schulte S; Molenaar J; Versteeg R; Thor T; Künkele A; Vandesompele J; Speleman F; Schorle H; Eggert A; Schramm A Oncogene; 2013 Feb; 32(8):1059-65. PubMed ID: 22484425 [TBL] [Abstract][Full Text] [Related]
23. MYCN gene amplification in patients with neuroblastic tumors. Estiar MA; Fazilaty H; Aslanabadi S; Seifi M; Varghaei P; Rezamand A Cell Mol Biol (Noisy-le-grand); 2014 Sep; 60(3):23-8. PubMed ID: 25231001 [TBL] [Abstract][Full Text] [Related]
24. Biological diagnosis for neuroblastoma using the combination of highly sensitive analysis of prognostic factors. Tajiri T; Tanaka S; Higashi M; Kinoshita Y; Takahashi Y; Tatsuta K; Suita S J Pediatr Surg; 2006 Mar; 41(3):560-6. PubMed ID: 16516635 [TBL] [Abstract][Full Text] [Related]
25. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma. Alaminos M; Mora J; Cheung NK; Smith A; Qin J; Chen L; Gerald WL Cancer Res; 2003 Aug; 63(15):4538-46. PubMed ID: 12907629 [TBL] [Abstract][Full Text] [Related]
26. Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma. Muth D; Ghazaryan S; Eckerle I; Beckett E; Pöhler C; Batzler J; Beisel C; Gogolin S; Fischer M; Henrich KO; Ehemann V; Gillespie P; Schwab M; Westermann F Cancer Res; 2010 May; 70(9):3791-802. PubMed ID: 20424123 [TBL] [Abstract][Full Text] [Related]
27. Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo. Johnsen JI; Segerström L; Orrego A; Elfman L; Henriksson M; Kågedal B; Eksborg S; Sveinbjörnsson B; Kogner P Oncogene; 2008 May; 27(20):2910-22. PubMed ID: 18026138 [TBL] [Abstract][Full Text] [Related]
28. Use of RNA interference to elucidate the effect of MYCN on cell cycle in neuroblastoma. Woo CW; Tan F; Cassano H; Lee J; Lee KC; Thiele CJ Pediatr Blood Cancer; 2008 Feb; 50(2):208-12. PubMed ID: 17420990 [TBL] [Abstract][Full Text] [Related]
32. [Study on MYCN gene amplification and CD44 expression in neuroblastoma]. Hu HL; He LJ Zhonghua Bing Li Xue Za Zhi; 2004 Aug; 33(4):332-6. PubMed ID: 15363318 [TBL] [Abstract][Full Text] [Related]
33. Survivin mRNA levels are associated with biology of disease and patient survival in neuroblastoma: a report from the children's oncology group. Miller MA; Ohashi K; Zhu X; McGrady P; London WB; Hogarty M; Sandler AD J Pediatr Hematol Oncol; 2006 Jul; 28(7):412-7. PubMed ID: 16825985 [TBL] [Abstract][Full Text] [Related]
35. Loss of caspase-8 expression does not correlate with MYCN amplification, aggressive disease, or prognosis in neuroblastoma. Fulda S; Poremba C; Berwanger B; Häcker S; Eilers M; Christiansen H; Hero B; Debatin KM Cancer Res; 2006 Oct; 66(20):10016-23. PubMed ID: 17047064 [TBL] [Abstract][Full Text] [Related]
36. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma. Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019 [TBL] [Abstract][Full Text] [Related]
37. The conundrum posed by cellular heterogeneity in analysis of human neuroblastoma. Ross RA; Spengler BA J Natl Cancer Inst; 2004 Aug; 96(16):1192-3. PubMed ID: 15316046 [No Abstract] [Full Text] [Related]
38. Long noncoding RNA in neuroblastoma: new light on the (old) N-Myc story. Pichler M; Calin GA J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 24906400 [No Abstract] [Full Text] [Related]
39. Circulating methylated-DCR2 gene in serum as an indicator of prognosis and therapeutic efficacy in patients with MYCN nonamplified neuroblastoma. Yagyu S; Gotoh T; Iehara T; Miyachi M; Katsumi Y; Tsubai-Shimizu S; Kikuchi K; Tamura S; Tsuchiya K; Imamura T; Misawa-Furihata A; Sugimoto T; Sawada T; Hosoi H Clin Cancer Res; 2008 Nov; 14(21):7011-9. PubMed ID: 18980997 [TBL] [Abstract][Full Text] [Related]
40. MYCN silencing induces differentiation and apoptosis in human neuroblastoma cells. Kang JH; Rychahou PG; Ishola TA; Qiao J; Evers BM; Chung DH Biochem Biophys Res Commun; 2006 Dec; 351(1):192-7. PubMed ID: 17055458 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]